Clinical Trial Update: Study Protocol for Rosiglitazone Versus Gliclazide in Diabetics With Angina [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing rosiglitazone versus gliclazide in adults with type 2 diabetes and angina has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina Pectoris
• Type 2 Diabetes Mellitus

Drugs mentioned

• Avandia (rosiglitazone)
• Diamicron (gliclazide)

Snippet

Sponsor: University of Glasgow | Conditions: Angina Pectoris, Diabetes Mellitus, Type 2 | Phase 4 | Status: WITHDRAWN